These data clearly indicatedthat a biologically significant interaction between selective COX-2 inhibitorsand PPAR-γ exists and that activation of PPAR-γ by these drugs may have detrimental, that istumor-promoting, effects on pancreatic cancer growth. Here, PPARG is linked to pancreatic neoplasm.